Literature DB >> 21971186

The influenza A virus protein PB1-F2: killing two birds with one stone?

Zsuzsanna T Varga1, Peter Palese.   

Abstract

PB1-F2 is a 90 amino acid protein that is expressed from the +1 open reading frame in the PB1 gene of some influenza A viruses. The PB1-F2 protein has been shown to contribute to viral pathogenicity, but the molecular mechanisms for mediating virulence have been unclear. Previous reports demonstrate that PB1-F2 promotes cell death, causes immunopathology and increases pro-inflammatory responses. Our group has identified a single point mutation from asparagine (N) to serine (S) at position 66 in the PB1-F2 protein that dramatically increases the virulence of highly pathogenic avian H5N1 influenza viruses and of the 1918 pandemic strain. In search for the mechanism by which PB1-F2 N66S increases pathogenicity, we have identified and characterized a novel function of PB1-F2, i.e. interferon antagonism, both in vitro and in the mouse model. Here, we discuss a hypothesis for a possible molecular link between the pro-apoptotic and anti-interferon functions of PB1-F2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971186      PMCID: PMC3260547          DOI: 10.4161/viru.2.6.17812

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  30 in total

1.  The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function.

Authors:  James S Gibbs; Daniela Malide; Felicita Hornung; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling.

Authors:  Takumi Koshiba; Kai Yasukawa; Yusuke Yanagi; Shun-ichiro Kawabata
Journal:  Sci Signal       Date:  2011-02-01       Impact factor: 8.192

3.  A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo.

Authors:  Gina M Conenello; Jennifer R Tisoncik; Elizabeth Rosenzweig; Zsuzsanna T Varga; Peter Palese; Michael G Katze
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

4.  MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response.

Authors:  Fajian Hou; Lijun Sun; Hui Zheng; Brian Skaug; Qiu-Xing Jiang; Zhijian J Chen
Journal:  Cell       Date:  2011-07-21       Impact factor: 41.582

5.  Mitofusin 2 inhibits mitochondrial antiviral signaling.

Authors:  Kai Yasukawa; Hiroyuki Oshiumi; Makoto Takeda; Naotada Ishihara; Yusuke Yanagi; Tsukasa Seya; Shun-ichiro Kawabata; Takumi Koshiba
Journal:  Sci Signal       Date:  2009-08-18       Impact factor: 8.192

6.  Caspase 3 activation is essential for efficient influenza virus propagation.

Authors:  Walter J Wurzer; Oliver Planz; Christina Ehrhardt; Martin Giner; Tobias Silberzahn; Stephan Pleschka; Stephan Ludwig
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

7.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.

Authors:  A García-Sastre; A Egorov; D Matassov; S Brandt; D E Levy; J E Durbin; P Palese; T Muster
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

8.  Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling.

Authors:  Oleg P Zhirnov; Hans-Dieter Klenk
Journal:  Apoptosis       Date:  2007-08       Impact factor: 4.677

9.  IPS-1 is crucial for DAP3-mediated anoikis induction by caspase-8 activation.

Authors:  H-M Li; D Fujikura; T Harada; J Uehara; T Kawai; S Akira; J C Reed; A Iwai; T Miyazaki
Journal:  Cell Death Differ       Date:  2009-07-31       Impact factor: 15.828

10.  Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1.

Authors:  Dmitriy Zamarin; Adolfo García-Sastre; Xiaoyao Xiao; Rong Wang; Peter Palese
Journal:  PLoS Pathog       Date:  2005-09-30       Impact factor: 6.823

View more
  19 in total

Review 1.  Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review.

Authors:  Olga Munoz; Marco De Nardi; Karen van der Meulen; Kristien van Reeth; Marion Koopmans; Kate Harris; Sophie von Dobschuetz; Gudrun Freidl; Adam Meijer; Andrew Breed; Andrew Hill; Rowena Kosmider; Jill Banks; Katharina D C Stärk; Barbara Wieland; Kim Stevens; Sylvie van der Werf; Vincent Enouf; Gwenaelle Dauphin; William Dundon; Giovanni Cattoli; Ilaria Capua
Journal:  Ecohealth       Date:  2015-01-29       Impact factor: 3.184

Review 2.  Variability among the neuraminidase, non-structural 1 and PB1-F2 proteins in the influenza A virus genome.

Authors:  William G Dundon
Journal:  Virus Genes       Date:  2012-01-20       Impact factor: 2.332

3.  The influenza A virus host shutoff factor PA-X is rapidly turned over in a strain-specific manner.

Authors:  Rachel Emily Levene; Shailab D Shrestha; Marta Maria Gaglia
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

4.  Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential.

Authors:  Zsuzsanna T Varga; Alesha Grant; Balaji Manicassamy; Peter Palese
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

5.  Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Virus Res       Date:  2013-03-14       Impact factor: 3.303

6.  Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.

Authors:  Manojkumar Ramanunninair; Jianhua Le; Shiroh Onodera; Andrew A Fulvini; Barbara A Pokorny; Jeanmarie Silverman; Rene Devis; Jennifer M Arroyo; Yu He; Alex Boyne; Jayati Bera; Rebecca Halpin; Erin Hine; David J Spiro; Doris Bucher
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

Review 7.  Innate immunity to H5N1 influenza viruses in humans.

Authors:  Irene Ramos; Ana Fernandez-Sesma
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

8.  Kinetic characterization of PB1-F2-mediated immunopathology during highly pathogenic avian H5N1 influenza virus infection.

Authors:  Olivier Leymarie; Grégory Jouvion; Pierre-Louis Hervé; Christophe Chevalier; Valérie Lorin; Jérôme Lecardonnel; Bruno Da Costa; Bernard Delmas; Nicolas Escriou; Ronan Le Goffic
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

9.  Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease.

Authors:  Julie L McAuley; Michelle D Tate; Charley J MacKenzie-Kludas; Anita Pinar; Weiguang Zeng; Andrea Stutz; Eicke Latz; Lorena E Brown; Ashley Mansell
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

10.  Dose- and time-dependent apoptosis induced by avian H9N2 influenza virus in human cells.

Authors:  Shahla Shahsavandi; Mohammad Majid Ebrahimi; Kaveh Sadeghi; Seyedeh Zahra Mosavi; Ashraf Mohammadi
Journal:  Biomed Res Int       Date:  2013-09-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.